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Abstract
Objective: Brown adipose tissue (BAT), a specialized tissue for thermogenesis, plays important roles for metabolism and
energy expenditure. Recent studies validated BAT’s presence in human adults, making it an important re-emerging target
for various pathologies. During this validation, PET images with
18F-FDG showed significant uptake of
18F-FDG by BAT under
certain conditions. Here, we demonstrated that Cerenkov luminescence imaging (CLI) using
18F-FDG could be utilized for
in vivo optical imaging of BAT in mice.
Methods: Mice were injected with
18F-FDG and imaged 60 minutes later with open filter and 2 minute acquisition. In vivo
activation of BAT was performed by norepinephrine and cold treatment under isoflurane or ketamine anesthesia. Spectral
unmixing and 3D imaging reconstruction were conducted with multiple-filter CLI images.
Results: 1) It was feasible to use CLI with
18F-FDG to image interscapular BAT in mice, with the majority of the signal (.85%)
at the interscapular site originating from BAT; 2) The method was reliable because excellent correlations between in vivo
CLI, ex vivo CLI, and ex vivo radioactivity were observed; 3) CLI could be used for monitoring BAT activation under different
conditions; 4) CLI signals from the group under short-term isoflurane anesthesia were significantly higher than that from the
group under long-term anesthesia; 5) The CLI spectrum of
18F-FDG with a peak at 640 nm in BAT after spectral unmixing
reflected the actual context of BAT; 6) Finally 3D reconstruction images showed excellent correlation between the source of
the light signal and the location and physical shape of BAT.
Conclusion: CLI with
18F-FDG is a feasible and reliable method for imaging BAT in mice. Compared to PET imaging, CLI is
significantly cheaper, faster for 2D planar imaging and easier to use. We believe that this method could be used as an
important tool for researchers investigating BAT.
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Introduction
Brown adipose tissue (BAT) is a specialized tissue for
thermogenesis in mammals, and it has been considered as
a furnace in the body for burning excess calories. The function
of BAT in mammals is to dissipate large amounts of chemical/food
energy as heat, thus maintaining the energy balance of the whole
body [1,2,3]. Investigations of BAT have been ongoing for
decades, particularly using animals. It has been considered that
BAT disappears from the body of adults and has no significant
physiological relevance in adult humans [1,4,5,6]. However,
recent rediscovery of BAT in human adults by PET-CT scan
has produced a new driving force for BAT studies
[7,8,9,10,11,12,13,14]. Multiple studies have demonstrated that
BAT mass levels inversely correlate with body-mass index (BMI),
and that physical exercises could increase BAT mass, suggesting
that BAT may play important roles in obesity and diabetes
[7,8,15,16,17]. In addition, BAT has emerged as an important
target for various other diseases such as neurodegenerative disease
and cancer [5,9,10,11,12]. Clearly, the ability to image BAT non-
invasively would aid in clinical staging of various diseases as well as
in drug development processes.
Cerenkov luminescence imaging (CLI) is a newly emerged
molecular imaging technology [18,19,20,21,22,23,24,25,26,27]. It
utilizes luminescence generated from the b
+ and b
2 decay of
radionuclides such as
18F and
131I in the medium. As a charged
particle (such as b
+ and b
2) travels, it polarizes molecules in the
medium [18,19,20]. When the polarized molecules relax back to
equilibrium they emit electromagnetic waves. As the particle
moves along its path, the waves destructively interfere with each
other and no radiation is observed. However, if the particle
velocity v is greater than the speed of light in the medium (c/n,
where c is the speed of light, and n is the index of refraction), then
a shockfront comprised from constructive interference is observed
as Cerenkov radiation. The intensity of the emitted Cerenkov
photons is proportional to the kinetic energy of the charged
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e62007particle, in this case, the b
+/2 ejected from the radionuclide [28].
As the condition that v.c/n in the medium, the energy threshold
necessary for Cerenkov light production varies for different media,
dependent on the index of refraction. [19,28]. In addition, the
spectrum of the radiation-luminescence consists of continuous
wavelengths throughout the ultraviolet (UV) and visible spectrum
[18,19,20], with the intensity distribution inversely proportional to
the square of the wavelength. It is conceivable that the light
emitted from the radionuclide with a shorter wavelength could be
used a replacement of ultraviolet (UV) light, while the longer
wavelength light could be used for in vivo imaging due to its
superior tissue penetration. We have previously demonstrated that
the UV portion of Cerenkov luminescence could be utilized for
in vivo photoactivation of caged luciferin [21], while Dothager and
Liu utilized this approach for quantum dots excitation [23,29].
Others have reported that CLI could be a reliable tool for imaging
tumors, assisting intraoperative surgical resection, endoscopic
imaging, and for monitoring therapeutic effectiveness of antican-
cer drugs [18,30,31,32,33,34]. Several excellent reviews have
summarized the advantages and disadvantages of this technology
[26,35,36]. Recently, Spinelli and Ackerman also demonstrated
that Cerenkov luminescence from alpha-emitter daughter prod-
ucts could be used for imaging [37,38]. In this report, we
demonstrated that CLI could be used for BAT imaging. BAT is an
ideal target for CLI due to the following reasons: 1) Location of
BAT in mice is unique since it is situated away from large organs
such as liver, heart, and stomach, and thus signal interference from
these large organs is minimal (Fig. 1a); 2) BAT location is shallow,
which allows for more photons to reach the detection camera; 3)
BAT is a whole mass organ; 4) BAT has a unique triangular
physical shape which is easy to distinguish from other tissues
(Fig. 1a).
PET (positron emission tomography) imaging confirmed the
significant uptake of
18F-FDG in BAT under certain conditions in
humans [7,8,10,13,39]. Previous animal studies also demonstrated
that
18F-FDG could be significantly taken up by BAT in mice
[40,41]. In this report, we hypothesized that BAT could be
optically imaged with
18F-FDG utilizing Cerenkov luminescence
imaging.
For small animal research, we believe that CLI imaging of BAT
could be a useful complementary method for PET imaging with
18F-FDG, particularly for laboratories without an accessible PET
scanner. Additionally, CLI imaging with an optical imaging system
is cheaper and therefore, more cost effective. For simple 2D planar
imaging it could be faster than PET imaging, and could potentially
be used for high throughput screening. Apart from the ability to
image BAT, our study also serves as an additional validation of
CLI as an emerging imaging modality.
Results
1. CLI Feasibility for BAT Imaging
To test whether CLI with
18F-FDG is capable of providing
significant signal and contrast, 10.3 MBq of
18F-FDG was
intravenously injected into nude mice. For each time point, mice
were anesthetized by isoflurane, and the CLI images were
acquired within 3 minutes after induction of anesthesia using
a whole-body optical imaging system. No stimulation for BAT
activation was applied. We found that CLI signals from
interscapular BAT (Fig. 1a) were remarkably bright at all time
points (30, 60, 120 minutes), and the contrast between BAT and
the adjacent reference area was apparent (Fig. 1b). Signal ratios of
BAT and the reference area were 2.37-, 2.49-, and 2.53-fold
respectively at 30, 60, and 120 minutes after injection. In-
terestingly, contours of BAT images closely resembled its physical
appearance (interscapular BAT of rodents consists of two lobes
that make a triangle contour) (Fig. 1a). These results suggested that
CLI imaging of BAT with
18F-FDG was feasible.
2. Validation of the CLI Signal from the Interscapular Area
To confirm whether the majority of the interscapular CLI signal
was from BAT, we first conducted biodistribution studies with CLI
signal and radioactivity countings from the dissected tissues. Both
CLI and radioactivity countings indicated that the heart and BAT
were the two primary tissues for
18F-FDG uptake, with BAT
displaying the highest uptake (Fig. 2a,b, and Fig. S1). Because the
heart is located more deeply than the interscapular BAT when
images were taken from the dorsal side, we speculated that the
majority of the CLI signal in the interscapular area originated
from BAT. To further validate this speculation, we imaged mice
before and after BAT removal, and compared the images. We
found that the majority of the signal (.85%) at the interscapular
site originated from BAT (Fig. 2c,d). The residual signal was
located near the upper rim of BAT and was most likely from the
remnants of BAT tissue and other surrounding tissues, such as
blood vessels, muscles, and bones.
Figure 1. CLI imaging of the interscapular BAT. (a) Triangular contour of interscapular BAT (blue arrow) in a mouse; (left) BAT is covered with
white adipose tissue, and (right) BAT is exposed. (b) CLI images of a mouse at 30, 60, 120 minutes after
18F-FDG (10.3 MBq) intravenous injection. The
images clearly outline the contour of BAT, even after 120 minutes of
18F-FDG injection. (c) Quantitative analysis of CLI signal from interscapular BAT
area and a reference area.
doi:10.1371/journal.pone.0062007.g001
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Since CLI imaging is still in the developmental stage, cross-
validation of in vivo CLI signals with ex vivo CLI signals, as well as
with its actual radioactivity, was necessary. It is known that
activation of BAT by cold exposure or drugs (such as
norepinephrine) is often needed to obtain reliable PET images
[8,10,39,40]. In our studies, we used similar methods to show the
reliability of Cerenkov luminescence imaging. We used norepi-
nephrine (NE) as a stimulator in these studies. Mice were
stimulated with NE followed by in vivo CLI with
18F-FDG.
Immediately after imaging, mice were sacrificed and BATs were
collected and subjected to ex vivo CLI imaging and radioactivity
measurements with a dosimeter. As expected, in vivo images of the
NE- treated group showed significantly brighter signals than that
of the non-treated control group (p,0.005, Fig. 3a and Fig. S2a).
Ex vivo CLI quantitation and dosimetry countings displayed
significantly higher values for the NE-treated group than for
controls as well (p,0.01, Fig. 3b–c, and Fig. S2b–c). To further
validate whether in vivo CLI signals reliably reflected the amount
of radioactivity caused by
18F-FDG accumulation in BAT, linear
regression fitting was used to evaluate a correlation between in vivo
CLI, ex vivo CLI, and ex vivo dosimetry countings. We found that
there was an excellent correlation between signals from in vivo CLI
and ex vivo radioactivity (r
2=0.95) (Fig. 3d), as well as between
signals from ex vivo CLI and ex vivo radioactivity (r
2=0.97) (Fig. 3e).
Due to the depth-penetrating limitation of optical imaging,
disparity between in vivo and ex vivo data often exists. However,
our data demonstrated a good correlation between in vivo CLI and
ex vivo CLI (r
2=0.96) (Fig. 3f). Taken together, our data suggest
that in vivo CLI imaging of BAT is reliable.
4. Monitoring BAT Activity using CLI
After confirmation of CLI feasibility and reliability for BAT
imaging with
18F-FDG, we utilized this method for monitoring
BAT activity. NE treatment and cold exposure are the most used
methods for BAT activation [8,10,39,40]. First, we compared
BAT activity in the same group of mice with and without NE
treatment under short (5 minute) isoflurane anesthesia. As
expected, we found that BAT activity under NE-treated condition
was significantly higher (1.23-fold) than without NE treatment
(Fig. 4a, b). Similar results were observed under the long (60
minute) isoflurane anesthesia. Interestingly, the difference in BAT
activity between NE-treated and non-treated animals was even
larger under long isoflurane anesthesia (60 minute) than under
short (5 min) isoflurane anesthesia (2.47 fold, Fig. 4c, d). PET
imaging of human subjects injected with
18F-FDG revealed that
the uptake of
18F-FDG in BAT was higher under cold exposure
than at room temperature [3,8,42]. In this report, we found that
there was a 39% increase of
18F-FDG uptake in the BAT of
animals stimulated with cold exposure (Fig. 4e, f).
Figure 2. Validation of CLI signal originating from BAT (n=3). (a–b) Biodistribution of
18F-FDG in dissected tissues. Radioactivity
quantifications (a) and CLI readings (b). Both methods indicated that BAT had the highest
18F-FDG uptake. (c–d) Representative images of mice
before (c, left) and after (c, right) BAT removal; (d) Quantification indicated that .85% CLI originated from BAT.
doi:10.1371/journal.pone.0062007.g002
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significant effect on BAT activity [10,41,43]. Fueger et al. reported
that
18F-FDG uptake in BAT was significantly reduced after 1
hour of ketamine anesthesia [41]. In the next study, we compared
CLI signal of
18F-FDG accumulation in mice under different
anesthesia regimens. We compared CLI signal from mice
subjected to isoflurane or ketamine/xylazine anesthesia. One
group of mice was subjected to isoflurane anesthesia for only for
a short period time needed for injection and imaging (about 5
minutes). After complete clearance of the previous
18F-FDG dose,
the same group was imaged again under ketamine/xylazine
anesthesia for about 70 minutes. Our imaging data revealed that
there was a 54% decrease in
18F-FDG BAT uptake in the group
anesthetized with ketamine compared to the isoflurane group
(Fig. 4g, h). Our results were similar to Fueger’s report, in which
18F-FDG uptake by BAT was dramatically depressed under long
anesthesia treatment [41].
5. Spectral Unmixing and Multispectral Cerenkov
Luminescence Tomography
In this report, we collected CLI signal with multiple filters, and
these data were used for spectral unmixing and multispectral
Cerenkov luminescence tomography [31].
18F-FDG (11.1 MBq)
was injected in mice and multispectral images of the animals’
Figure 3. Reliability correlation studies of in vivo CLI imaging, ex vivo CLI imaging, and radioactive dosimetric countings of BAT. (a)
In vivo CLI images of mice injected with
18F-FDG under ketamine/xylazine anesthesia without (top panel, mice #1–4) and with NE treatment (lower
panel, mice #5–8). (b) Ex vivo CLI images of BAT of mice in (a). (c) Dosimetric countings of ex vivo BAT in (b). (d) Correlation between in vivo CLI
signals and dosimetric countings. (e) Correlation between ex vivo CLI signals and dosimetric countings. (f) Correlation between ex vivo CLI signals and
in vivo CLI signals. Correlation plots in D-F suggest that in vivo CLI signals, ex vivo CLI signals, and ex vivo radioactivity measurements were highly
interrelated.
doi:10.1371/journal.pone.0062007.g003
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20 nm-wide filters at 580, 600, 620, 640, 660 and 680 nm (raw
images are shown in Fig. S3). Spectral unmixing was conducted
with commercial software package to separate two components
(BAT and unspecific signals). From Fig. 5a, it is clear that the
unmixed component #1 (Unmix #1) represented unspecific CLI
from
18F-FDG, with no particular area highlighted. The spectrum
(blue line in Fig. 5d) further confirmed that the Unmix #1
represented an unspecific CLI signal, because the spectrum
matched with the emission spectrum of
18F in pure media, in
which the CLI intensity is inversely correlated with the square of
the wavelength [18,19,20]. This indicates that the Cerenkov
emissions in Unmix #1 are from very shallow depths, such as
18F-
FDG accumulation in the skin, as the observed emission spectrum
is not affected by tissue absorption. Unmixed component #2
(Unmix #2) reflected the signals from interscapular BAT (Fig. 5b).
Notably, the spectrum peak (red line) was around 640 nm and the
signal considerably inflated with the increase of the wavelength
before reaching the peak, while the intensity of CLI was not
dramatically decreased once it reached the peak (red line in
Fig. 5d). This phenomenon is probably due to two facts: 1) the
light absorption of hemoglobin in blood and cytochrome c in
mitochondria for short wavelength CLI (,640 nm;BAT contains
more mitochondria and is highly vascularized compared to other
nearby tissues [1]); 2) better tissue penetration of the emitted light
with longer wavelength.
The 3D reconstruction was conducted with multispectral
Cerenkov luminescence tomography (msCLT), which is based
on a set of 2D planar CLI images acquired using a number of
narrow bandpass filters. 3D image reconstruction utilizes the
distinctive diffuse information at each wavelength [31,44]. The
advantage of this method is that it provides depth resolution and
localization without requiring multiple views of the animal.
Recently, several other groups have also demonstrated the
feasibility of 3D CLI reconstruction [30,45,46,47]. In the process
of msCLT, the 1/l
2 wavelength dependence of the Cerenkov
spectrum [18,19,20] was incorporated in the model of multi-
spectral diffuse light propagation. The wavelength-dependent
scattering and attenuation coefficients were selected depending on
the imaged tissues [44]. The reconstructed 3D images revealed
that CLI signal originated from shallow locations (Fig. 6b), and
that a significant portion of the signal was coming from
interscapular BAT (Fig. 6a–d). This signal was particularly obvious
in coronal images that clearly displayed two lobes of BAT (Fig. 6a,
d). Notably, the contour was very similar to the physical triangle
shape of BAT shown in Fig. 6e.
Discussion
BAT or brown fat, widely known as ‘good fat,’ has been
considered as a furnace in the body for burning excess calories.
The most distinct characteristics of BAT include a large number of
mitochondria, abundant UCP-1 (uncoupling protein-1) expres-
sion, and numerous small oil droplets in a single cell, as well as
significant vascularization of BAT tissue [7,10,12,48,49]. These
characteristics strongly indicate that BAT plays important roles in
metabolism and energy expenditure under both healthy and
disease status. In humans, BAT is highly abundant in embryonic
and early postnatal stages, but is drastically reduced or is
considered to have no physiologic relevance in adult humans
[1,2,3]. However, the importance of BAT has recently ‘‘re-
emerged’’ in new studies using PET imaging. PET images have
shown that BAT is still present in adults in the upper chest, neck
and other locations [7,10,12]. Recently, Cypess et al. imaged and
analyzed 3,640 patients and showed that BMI (body mass index)
inversely correlated to the amount of brown adipose tissue,
suggesting that BAT is an important target in obesity and diabetes
[7]. Other studies have also demonstrated that both BMI and
body fat percentage had a significant negative correlation with
Figure 4. CLI imaging with
18F-FDG for monitoring BAT activation. (a) Representative CLI images of BAT of mice with (left) and without
(right) NE stimulation under short isoflurane anesthesia. (b) Quantitative analysis of the CLI signals from the two groups in a (n=4 for each group). (c)
Representative CLI images of BAT of mice with (left) and without (right) NE treatment under long isoflurane anesthesia (60 minutes). (d) Quantitative
analysis of the CLI signals from the two groups shown in c (n=3–4 for each group). (e) Representative CLI images of BAT of mice with (left) and
without (right) cold stimulation under short isoflurane anesthesia. (f) Quantitative analysis of the CLI signals from the two groups shown in e (n=3–4
for each group). (g) Representative CLI images of BAT at 60 minutes after
18F-FDG injection under short isoflurane anesthesia (5 min) (left) and
ketamine/xylazine anesthesia (70 minutes) (right). (h) Quantitative analysis of the CLI signals from the two groups shown in g (n=4 for each group).
doi:10.1371/journal.pone.0062007.g004
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BAT [8,17]. Moreover, it has been reported that individual
differences in energy expenditure could have significant, long-term
effects on body weight, and that relatively low energy expenditure
predicts a weight gain [8,17]. Recently Nagajyothi et al. suggested
that BAT is one of the targets for some parasite infection [50],
while Herrero et al. indicated that BAT is related to inflammation
[51]. There are indications that BAT has great significance during
the process of ageing [11] and that its activity is closely related to
exercise [15,16]. In addition, to improve the therapy of obesity
and diabetes, increasing efforts have been put into harnessing the
benefits of BAT. These efforts include the engineering and
transplantation of BAT and the promotion of BAT mass by drug
treatment [12,52].
Given the importance of BAT for various diseases, we believe
that new imaging techniques would be highly beneficial for its
Figure 5. Spectral unmixing for unspecific CLI and BAT CLI. (a) Unmix #1 showed that unspecific CLI signal from
18F-FDG was distributed
over the whole body (the unmixed spectrum for this image is shown in (d) (blue line)). (b) Unmix #2 indicated that the majority of CLI at interscapular
site was from BAT (the unmixed spectrum is shown in (d) (red line)). CLI peak was around 640 nm. (c) Merged image of Unmix #1 and #2. (d) The CLI
spectra of Unmix #1 and #2.
doi:10.1371/journal.pone.0062007.g005
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is PET imaging with
18F-FDG. PET and CLI imaging both have
advantages and disadvantages in terms of cost, sensitivity, spatial
and temporal resolution, high throughput and handiness. The
advantages of CLI include its low cost imaging system, high
sensitivity, potential high spatial resolution with certain radio-
nuclides [20], capacity for high throughput, and ease of learning
and usage. Its major disadvantages include tissue penetrating
limitation and low sensitivity for deep targets [26,35,36].
For small animal imaging, the obvious benefits of CLI include
a low cost of the imaging system, fast image acquisition for 2D
planar imaging, and high throughput capacity. Although CLI
signal from
18F-FDG is not very strong, the highly sensitive, cooled
camera (290uC) in optical systems could make each imaging
acquisition time considerably shorter than that of PET imaging. In
our case, high quality CLI images with
18F-FDG (7.4–11.1 MBq
with i.v. injection) were obtained using a 2-minute acquisition
time, while PET imaging normally required more than 5 minutes
for each imaging session. However, advanced CLI techniques such
as multi-spectral imaging and 3D tomography would normally
need longer acquisition times (10–30 minutes). Recently, studies
have indicated that the sensitivity of CLI is comparable to PET for
shallow targets such as xenografted tumors, lymph nodes and the
thyroid [18,20,34,54]. Our data also indicated that CLI is a very
sensitive method for BAT imaging both in vivo and ex vivo. CLI
signal from BAT was detectable at even two hours after 10.3 MBq
18F-FDG injection (Fig. 1b,c) and ex vivo biodistribution indicated
that 7.4 KBq
18F-FDG could produce considerable CLI signal
(Fig. S1).
Biodistribution data measured by radioactivity counting and
CLI were very similar. Heart and BAT were the tissues with the
highest
18F-FDG uptake in both modalities. However, the CLI
signal ratio of BAT/heart was higher than that of radioactivity
counting (2.92 vs 1.76, Fig. 2a,b). This was probably due to the
low CLI signal from the heart, in which a large amount of blood
could absorb the emitted CLI light. CLI is a planar imaging
method, which collects signals from the body surface; therefore, it
is necessary to verify whether the CLI signal at the interscapular
site is from BAT. Our biodistribution data indicated that the
majority CLI signal at the interscapular site was from BAT, and
a further BAT removal experiments validated this indication. Our
correlation studies between in vivo CLI, ex vivo CLI, and
Figure 6. Multispectral Cerenkov luminescence tomography. (a–d) 3D reconstruction of the images. Interscapular BAT could be seen in
coronal (a), sagittal (b), and transverse views (c), as well as in the 3D image (d); (e) Physical BAT shape is shown (blue arrow) which correlated with
reconstructed images.
doi:10.1371/journal.pone.0062007.g006
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reliable. Excellent correlation of in vivo CLI and ex vivo CLI from
dissected BAT again suggested that in vivo CLI signal at the
interscapular site was primarily from BAT. Although we did not
conduct PET imaging with
18F-FDG to correlate with our in vivo
CLI signal, the radioactivity counting could be considered
a reasonable surrogate for PET imaging because both methods
reflect the actual amount of radioactive substance in the target
tissue.
In human studies, it has been reported that PET imaging signals
of BAT deposits with
18F-FDG varied considerably under different
conditions. For instance, only 3%–8% of patients’ BAT stores
could be clearly visualized with 18F-FDG if no cold or drug
stimulation was applied. On the contrary, after cold activation
.95% of patients’ BAT could be imaged with
18F-FDG [7,8].
However, we observed that this was not the case for mice, because
there was an apparent CLI signal even under non-treated
conditions (Fig. 1b). This is probably due to the certain level of
BAT activation in mice that they maintain to keep their body
warm, particularly nude mice. Spectral unmixing is a very useful
technique in fluorescence imaging, which could enable the
removal of autofluorescence from a subject. However, it is not
often used in cases of bioluminescence imaging because bio-
luminescence background from non-luciferase expressing tissue is
always negligible. Nonetheless, the uptake of
18F-FDG in mice is
not highly target-specific (even though heart, BAT, and brain are
the major targets) and some unspecific CLI signals are detectable.
We found that this unspecific uptake problem could be solved with
the spectral unmixing technique. The unmixed spectrum of
unspecific
18F-FDG in skin and superficially in muscle was very
similar to the CLI spectrum of pure
18F
- in water [18,20]. The CLI
spectrum of BAT reflected the actual surroundings of BAT, which
contain abundant heme proteins, which form hemoglobin in blood
and cytochrome C in mitochondria. Our 3D reconstruction was
conducted with a commercial optical system using the diffusive
properties of different wavelengths. The method allowed us to
avoid using a complicated optical imaging system that requires
acquisition of multiple-angle view images and therefore could be
easily operated and accessed. The 3D images indicated that the
majority of CLI signals originated from shallow locations, but not
from the heart or other organs. This result was consistent with our
biodistribution studies. It is widely known that 2D planar optical
imaging is semi-quantitative [53], so is 2D CLI used in this report.
Although 3D CLI tomography imaging could provide better
quantification, and great efforts have been put into different
reconstruction methods [31,45,54], commercially available soft-
ware packages are still not available yet. Therefore the accessibility
of 3D CLI is the bottleneck for wide application of this advanced
technology. Hopefully, this limitation could probably be overcome
in the near future.
For the very recent development of this technology, it is very
exciting that the first human CLI imaging has been successfully
demonstrated [55]. Conceivably, CLI imaging of BAT in the neck
area in humans is possible due to its shallow location.
In summary, we demonstrated that CLI with
18F-FDG could be
used as a reliable method to image BAT and to monitor its
activation. This method is particularly useful for small animal
models where BAT location is ideal for optical registration.
Compared to
18F-FDG PET imaging, CLI is much cheaper,
faster, and can be used for in vivo high throughput screening as
well. In addition, our study also showed that 3D tomography of
CLI is feasible and that 3D volume quantification is possible for
future studies. For small animal imaging, we believe that CLI
imaging of BAT could be a useful complementary tool to PET
imaging in small animals for researchers investigating BAT.
Experiments
Female nu/nu mice 4–8 weeks of age were purchased from
Massachusetts General Hospital Radiation Oncology breeding
facilities. All experimental procedures were approved by the
Subcommittee on Research Animal Care at Massachusetts
General Hospital. CLI imaging was performed using an
IVISHSpectrum animal imaging system (Perkin Elmer/Caliper
LifeSciences, Hopkinton, MA). Image analysis was conducted
using LivingImageH 4.2 software. The
18F-FDG images were not
decay corrected for all quantification because our comparisons
between different animal groups were made at the same time-
points, and acquisition parameters were the same.
18F-FDG was
purchased from IBA Molecular.
1. Feasibility Study
Mice (n=3) were anesthetized with isoflurane balanced with
oxygen for 5 minutes and injected with 10.3 MBq of
18F-FDG
intravenously. Injected mice were then subjected to luminescence
imaging at 30, 60, and 120 minutes after
18F-FDG injection with
the following parameters: open filter, f=1, bin=8, FOV=D, and
exposure time=120 s.
2. Validation of BAT Location by CLI and Biodistribution
Studies
Mice (n=3) were anesthetized with isoflurane balanced with
oxygen for 5 minutes and injected with 10.3 MBq of
18F-FDG
intravenously. Mice were sacrificed at 60 minutes after injection.
The skin from the interscapular area was removed and mice
underwent imaging before and after BAT removal, using the same
parameters as listed above in the feasibility study section. After
imaging, organs were dissected, collected and weighed, and
subjected to optical imaging (open filter, f=1, bin=8, FOV=D,
and exposure time=120 s) and to radioactivity counting with
dosimeters. The distribution of signals was normalized to the
weight of the tested organs.
3. Reliability Studies with Ketamine Anesthesia and NE
Treatment
Nude mice (n=8) were divided into two groups (n=4 each).
One group was injected with norepinephrine (NE) (50 uL,
10 mM) intraperitoneally. The second group served as a non-
injected control. After 30 minutes, both groups were injected
intraperitoneally with ketamine/xylazine and kept under anesthe-
sia for the following 60–70 minutes at room temperature. Once
mice were anesthetized,
18F-FDG (8.1 MBq) was intravenously
injected into each mouse. Mice were imaged at 60 minutes after
18F-FDG injections, using the same parameters as for the
feasibility study. For the correlation study, mice were sacrificed
immediately after imaging, BAT was excised, and CLI imaging
and a dosimeter counting were performed.
4. Monitoring Activation with NE and Cold Exposure
Under Isoflurane Anesthesia
A similar procedure for NE activation and cold exposure was
followed as above, except isoflurane was used and anesthesia time
lasted for 5 minutes before each image acquisition (n=4). For long
isoflurane anesthesia (60 minutes), mice were kept in an isoflurane
induction chamber after
18F-FDG injection. For cold exposure
study, mice were placed in a cold room (4uC) for 4 hours before
Cerenkov Imaging of Brown Adipose Tissue
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from anesthesia until the images were acquired. The body
temperatures of the mice in the cold room were measured with
a rectal thermometer and we found that their temperatures were
about 30uC.
5. Spectral Unmixing and Multispectral Cerenkov
Luminescence Tomography Studies
Mice were anesthetized for 5 minutes with isoflurane followed
by intravenous injection of 11.1MBq
18F-FDG. Multispectral
images were acquired with the following parameters: f=1,
bin=16, acquisition time=300s per filter, emission filters=580,
600, 620, 640, 660 and 680 nm (raw images are shown in Fig. S2).
Spectral unmixing was conducted with Living Imaging 4.31
software from Caliper, a Perkin Elmer Company, and two
components and automatic unmixing were used. A 3D re-
construction was conducted according to the method reported
by Kuo et al. [31,44] and using in-house software from Caliper,
a Perkin Elmer Company. The Cerenkov emission spectrum was
incorporated into the model of diffuse light propagation. Tikhonov
regularization was applied in the non-negative least squares
optimization of the residuals, and the surface tomography
generated from structure light imaging was used for 3D image
co-registration.
Supporting Information
Figure S1 Representative CLI images of dissected
tissues (n=3). 1) liver, 2) heart, 3) lung, 4) brain, 5) muscle, 6)
kidney, 7) spleen, 8) intestine, 9) bladder, 10) skin, 11) blood, 12)
stomach, 13) white fat from belly, 14) BAT.
(TIF)
Figure S2 Quantitative analysis of signals of the NE-
treated group and the control group. Radioactivity reading
(a), in vivo CLI signals (b), and ex vivo CLI signals (c) (n=4 for each
group).
(TIF)
Figure S3 Raw images for spectral unmixing and
multispectral Cerenkov luminescence tomography im-
aging.
(TIF)
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